1. Others

Others

There are a number of inhibitors, agonists, and antagonists which we cannot make precise classification because the research area is still unknown.

Others Related Products (73745):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-156629
    Orziloben 1555822-28-0 ≥98.0%
    Orziloben is a medium chain fatty acid (MCFA) analogue.
    Orziloben
  • HY-156957
    5-CNAC disodium 300718-75-6 99.72%
    5-CNAC disodium is an orally active enhancer of absorption, with no pharmacological activity on its own. 5-CNAC disodium can significantly enhance the absorption efficiency of the drug (such as Salmon calcitonin (HY-P0090)) when administered together with it in the gastrointestinal tract. 5-CNAC disodium binds reversibly and non-covalently to peptide drugs, protecting them from degradation by gastrointestinal enzymes, increasing their lipid solubility, promoting passive transcellular absorption, and not damaging the integrity of the intestinal epithelium. 5-CNAC disodium can be used in the research of adjuvants for orally administered peptide agents.
    5-CNAC disodium
  • HY-157542
    CG428-NEG 2714560-39-9
    CG428-NEG is a TRK degrader negative control. CG428 (HY-137465) inhibits cell growth and reduce TPM3-TRKA levels.
    CG428-NEG
  • HY-157582
    MS39N 2675490-96-5 98.0%
    MS39N (compound 27) is a negative control for MS39 that binds EGFR without inducing degradation.
    MS39N
  • HY-157618
    18:0-18:1 PG sodium 322647-48-3 99.0%
    18:0-18:1 PG sodium is a hydrogenated phospholipid that contributes to the stability of photosystem I and II protein complexes and plays a role in bacterial defense mechanisms, featuring two extra methylene groups in its saturated sn-1 chain, and is present in the thylakoid membranes of higher plants and cyanobacteria.
    18:0-18:1 PG sodium
  • HY-158586
    3'-Azido-ddATP sodium solution (100 mM) 1383937-03-8 98.88%
    3'-Azido-ddATP sodium solution (100 mM) is a labeled modified deoxyoligonucleotide (dNTP) that can release pyrophosphate to produce fluorescence and has special applications in gene synthesis and sequencing.
    3'-Azido-ddATP sodium solution (100 mM)
  • HY-158674
    3'-P-dGTP sodium,100 mM Solution 99.29%
    3'-P-dGTP sodium,100 mM Solution is a labeled modified deoxyoligonucleotide (dNTP) that can release pyrophosphate to produce fluorescence and has special applications in gene synthesis and sequencing.
    3'-P-dGTP sodium,100 mM Solution
  • HY-158800
    1-NBD-decanoyl-2-decanoyl-sn-glycerol 2309189-98-6 99.40%
    1-NBD-decanoyl-2-decanoyl-sn-glycerol is a diacylglycerol (DAG) derivative, which is labeled with a fluorescent group NBD. 1-NBD-decanoyl-2-decanoyl-sn-glycerol is the substrate for diacylglycerol kinase (DGK), and can be used for quantitative detection of the DGF enzyme kinetics in vitro, and the changes in DAG and PA during cell signaling.
    1-NBD-decanoyl-2-decanoyl-sn-glycerol
  • HY-160428
    DMTr-5-fluoro-2'-deoxycytidine-phosphoramidite 143774-48-5
    DMTr-5-fluoro-2'-deoxycytidine-phosphoramidite (compound 1B) is a phosphoramidite of 5-Fluoro-2'-deoxycytidine.
    DMTr-5-fluoro-2'-deoxycytidine-phosphoramidite
  • HY-160512
    Lipid 9 2982842-90-8
    Lipid 9 is an ionizable lipid that can be used to synthesize lipid nanoparticles (LNP) for delivering mRNA and other payloads.
    Lipid 9
  • HY-160869
    Firefly luciferase-IN-2 796108-95-7
    Firefly luciferase-IN-2 (compound 5j) is an inhibitor of ATP-dependent luciferase (Firefly luciferase), the major light-emitting enzyme in fireflies and kowtow bugs. Firefly luciferase-IN-2 inhibits P. pyralis luciferase with an IC50 of 0.15 μM, while the inhibitory potency against R. reniformis is not significant.
    Firefly luciferase-IN-2
  • HY-160884
    DMT-2'-OMe-D-Ribitol phosphoramidite 1470023-72-3 99.23%
    DMT-2'-OMe-D-Ribitol phosphoramidite (compound 9) is an abasic phosphoramidite monomer that can be used to introduce the abasic group Y34 into oligonucleotides.
    DMT-2'-OMe-D-Ribitol phosphoramidite
  • HY-161088
    Anti-aging agent 1 1884611-28-2 98.75%
    Anti-aging agent 1 (compound 24) is a derivative of piperlongumine (HY-N2329) (PL). Anti-aging agent 1 exhibits a 50-fold enhancement in senolytic activity against senescent WI-38 fibroblasts compared to PL.
    Anti-aging agent 1
  • HY-163213
    Psoralen-triethylene glycol azide 1352815-11-2 99.2%
    Psoralen-triepthylene glycol azide is a compound used to probe the structure and conformation of RNA in living cells, using matching RNA crosslinking and deep sequencing or comradery methods.
    Psoralen-triethylene glycol azide
  • HY-164066
    Sodium Acetylated Hyaluronate 287390-12-9
    Sodium Acetylated Hyaluronate is an acetylated hyaluronic acid derivative with anti-wrinkle and deep skin penetration properties, which can be used in skin aging research and cosmetic development.
    Sodium Acetylated Hyaluronate
  • HY-164581
    DMTr-2'-O-C22-rG(ibu)-3'-CE-Phosphoramidite 2923115-75-5 98.0%
    DMTr-2'-O-C22-rG (ibu)-3'-CE-Phosphoramidite is an RNA phosphoramidite monomer for oligonucleotide synthesis. DMTr-2'-O-C22-rG (ibu)-3'-CE-Phosphoramidite enables site-specific introduction of 2'-O-C22 lipophilic modification at guanosine positions to construct double-stranded RNA (dsRNA) molecules with extrahepatic delivery capability. DMTr-2'-O-C22-rG (ibu)-3'-CE-Phosphoramidite supports target gene silencing in skeletal muscle, cardiac muscle and adipose tissue by enhancing the lipid solubility and tissue uptake efficiency of dsRNA. DMTr-2'-O-C22-rG (ibu)-3'-CE-Phosphoramidite can be used for the construction and mechanism research of nucleic acid silencing molecules.
    DMTr-2'-O-C22-rG(ibu)-3'-CE-Phosphoramidite
  • HY-164582
    DMTr-2'-O-C22-rC(Ac)-3'-CE-Phosphoramidite 2923115-93-7 98.0%
    DMTr-2'-O-C22-rC (Ac)-3'-CE-Phosphoramidite is an RNA phosphoramidite monomer. DMTr-2'-O-C22-rC (Ac)-3'-CE-Phosphoramidite enables site-specific introduction of 2'-O-C22 lipophilic modification at cytidine positions during oligonucleotide synthesis, which is used to construct double-stranded RNA (dsRNA) molecules with extrahepatic delivery capability. DMTr-2'-O-C22-rC (Ac)-3'-CE-Phosphoramidite supports target gene silencing in skeletal muscle, cardiac muscle and adipose tissue by enhancing the lipophilicity and tissue uptake efficiency of dsRNA. Construction and mechanism study of DMTr-2'-O-C22-rC (Ac)-3'-CE-Phosphoramidite nucleic acid silencing molecules.
    DMTr-2'-O-C22-rC(Ac)-3'-CE-Phosphoramidite
  • HY-164583
    DMTr-2'-O-C22-rA-3'-CE-Phosphoramidite 2923115-67-5 98.0%
    DMTr-2'-O-C22-rA-3'-CE-Phosphoramidite is an RNA phosphoramidite monomer. DMTr-2'-O-C22-rA-3'-CE-Phosphoramidite allows site-specific introduction of a 2'-O-C22 lipophilic modification at adenosine positions to construct double-stranded RNA (dsRNA) molecules with extrahepatic delivery capability. DMTr-2'-O-C22-rA-3'-CE-Phosphoramidite supports target gene silencing in skeletal muscle, cardiac muscle and adipose tissue by enhancing the lipophilicity and tissue uptake efficiency of dsRNA. DMTr-2'-O-C22-rA-3'-CE-Phosphoramidite can be used for the construction and mechanism research of nucleic acid silencing molecules.
    DMTr-2'-O-C22-rA-3'-CE-Phosphoramidite
  • HY-164598
    Amino-tri-(azide-PEG4-ethoxymethyl)-methane 99.81%
    Amino-tri-(azide-PEG4-ethoxymethyl)-methane is a multi-arm PEG product.
    Amino-tri-(azide-PEG4-ethoxymethyl)-methane
  • HY-165041
    1,3-Dioleoyl-2-stearoyl glycerol 2410-29-9 99.9%
    1,3-Dioleoyl-2-stearoyl glycerol (1,3-Olein-2-stearin) is a compound mentioned in the study of triglyceride composition in bovine milk fat. It has been identified and quantified by various methods, and its proportion and type in bovine milk fat have been determined.
    1,3-Dioleoyl-2-stearoyl glycerol